Engineering human protein switches for functional control of CARs and transcription factors via oral drug administration
Sylvander, E.; Munoz-Lopez, A.; D Accardio, G.; Emminger, D.; Mouratidis, K.; Engert, F.; Baik, H.; Balaji, S.; Michls, T.; Buri, M. C.; Maresch, D.; Urbanetz, A.; Schaefer, M.; Mittelstaet, J.; Zuber, J.; Rosato, A.; Engels, B.; Zajc, C. U.; Traxlmayr, M.; Lehner, M.
Show abstract
While CAR T cells have revolutionized the treatment of certain hematologic malignancies, they can cause severe toxicities, which are expected to be exacerbated with next-generation CAR Ts engineered for improved proliferation, persistence, and efficacy. Therefore, regulatory systems are urgently needed to be able to control these living drugs directly in patients. Here, we engineered a molecular switch, in which the interaction of two human proteins is efficiently induced with the orally available and non-toxic drug A1120. We demonstrate the versatility of this switch by regulating CAR signaling and transcriptional activity in human T cells in vitro and in vivo. Both systems were tightly controlled in the absence of the drug but strongly activated upon administration of the small molecule. Since this switch enables the regulation of diverse systems including CARs and transcription factors, we anticipate that it represents an important step towards next-generation cellular therapies with improved safety and efficacy.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.